Computational models to aid personalized stroke decision-making in ad/adrd
Active Grant Awarded
- Award ID
- K23AG097999
- Recipient
-
Regents Of The University Of Minnesota UEI KABJZBBJ4B54
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $174,288
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date 4% complete
- Place of performance
- Minneapolis, MN 55455, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services, National Institutes of Health, National Institute on Aging awarded Grant K23AG097999 to Regents of the University of Minnesota, doing business as Office Sponsored Projects Administration, with $174,288 obligated on September 9, 2026, under the Aging Research program (CFDA 93.866). The award funds computational models for personalized stroke decision-making in older adults with Alzheimer's disease and related dementias (AD/ADRD). Aim 1 develops and validates machine learning-based incident phenotyping to identify AD and determine when it was first diagnosed, using a longitudinal EMR dataset of well-defined acute ischemic stroke cases, and yields scalable tools for reproducible AD identification across real-world EMR systems. Aim 2 applies causal modeling to a well-characterized stroke dataset with clinical, imaging, and outcome data to identify causal factors influencing outcomes and to estimate the effects of intravenous thrombolysis (IVT) and endovascular therapy (EVT) in patients with AD. Place of performance is Minneapolis, Minnesota 55455, USA, and the ultimate completion date is May 31, 2031. The program supports biomedical, social, and behavioral research on the aging process, with the National Institute on Aging's mission emphasizing prevention and treatment of Alzheimer's disease and related dementias.
Description
- Abstract
- Alzheimer's disease (ad) and acute ischemic stroke (AIS) are common and disabling diseases in older adults and frequently CO-occur. Yet patients with ad have been systematically excluded from clinical trials of stroke reperfusion therapies (IV thrombolysis (IVT) and endovascular therapy (EVT)), leaving clinicians without data to guide treatment. Observational studies suggest these therapies may be safe and potentially beneficial, but results are inconsistent and rarely distinguish ad from other dementias. This represents a critical GAP in stroke and aging research: existing data sources and analytic frameworks are insufficient to evaluate outcomes and treatment effects of stroke therapies in patients with ad, limiting evidence-based and goal-concordant care. The long-term objective of this research is to improve precision and safety in stroke treatment for older adults with ad. The central hypothesis is that complementary computational approaches-machine learning (ML)- based incident phenotyping to accurately identify ad and its onset, and causal modeling to reveal determinants of outcomes and treatment effects-can together overcome current data limitations and generate the evidence needed to guide stroke care in this understudied population. Aim 1 will develop and validate ML-based incident phenotyping methods to identify ad and determine when IT was first diagnosed in a longitudinal EMR dataset of well-defined AIS cases. This will yield scalable, efficient tools for reproducible ad identification that can be applied across real-world EMR systems and used to accelerate large-scale, multi-institutional research in stroke and dementia. Aim 2 will use causal modeling in a well-characterized stroke dataset with detailed clinical, imaging, and outcome data to identify causal factors influencing outcomes and estimate the effects of IVT and EVT in patients with ad. This project is innovative in uniting complementary computational methods to address treatment-effect questions in a population historically excluded from clinical trials. Its significance is in producing validated analytic tools, high-quality datasets of ad patients with AIS, and foundational evidence to inform clinical decision-making. Expected outcomes include a scalable incident phenotyping framework, reproducible causal models, and durable infrastructure for future R01-level studies extending these methods to other dementias and therapeutic areas. This K23 award will also provide critical career development through advanced training in machine learning, causal modeling, and informatics, supporting DR. Mccullough-hicks' transition to an independent investigator advancing precision medicine and goal-concordant stroke care for older adults with dementia. This work directly supports the national institute on aging's mission to improve understanding of ad and to develop interventions that enhance health and quality of life in aging populations.
Quick answers
Who received award K23AG097999?
K23AG097999 was awarded to Regents Of The University Of Minnesota by National Institute on Aging (National Institutes of Health) on September 9, 2026.
How much is award K23AG097999 worth?
$174,288 has been obligated on K23AG097999.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award